Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1048943
rs1048943
CYP1A1
0.050 GeneticVariation BEFREE <b>Conclusion.</b> This meta-analysis revealed a clear association between rs104</span>8943 and rs4646903 polymorphisms of the <i>CYP1A1</i> gene but not between CYP1B1 rs10012, rs162549, rs1800440, and rs2551188 polymorphisms and the risk of PCa. 30765615

2019
dbSNP: rs2551188
rs2551188
CYP1B1 ; CYP1B1-AS1
0.030 GeneticVariation BEFREE <b>Conclusion.</b> This meta-analysis revealed a clear association between rs1048943 and rs4646903 polymorphisms of the <i>CYP1A1</i> gene but not between CYP1B1 rs10012, rs162549, rs1800440, and rs2551188 polymorphisms and the risk of PCa. 30765615

2019
dbSNP: rs4646903
rs4646903
CYP1A1
0.010 GeneticVariation BEFREE <b>Conclusion.</b> This meta-analysis revealed a clear association between rs1048943 and rs4646903 polymorphisms of the <i>CYP1A1</i> gene but not between CYP1B1 rs10012, rs162549, rs1800440, and rs2551188 polymorphisms and the risk of PCa. 30765615

2019
dbSNP: rs2394882
rs2394882
POU5F1 ; TCF19
0.010 GeneticVariation BEFREE <b>Conclusion:</b> Our results suggest that rs2394882 is prognostically relevant in prostate cancer, possibly by modulating the expression of the CSC gene <i>POU5F1</i>. 29104488

2017
dbSNP: rs8752
rs8752
HPGD
0.010 GeneticVariation BEFREE <b>Conclusions:</b> rs8752 in the 3'untranslated region (UTR) of the 15-hydroxyprostaglandin dehydrogenase (<i>HPGD</i>) gene was found to be responsible for the susceptibility to prostate cancer in Chinese individuals. 29187884

2017
dbSNP: rs662
rs662
PON1
0.020 GeneticVariation BEFREE <b>Conclusions:</b> We reported by the first time a correlation between rs662 (PON1) and PCa aggressiveness. 31647334

2019
dbSNP: rs1056836
rs1056836
CYP1B1
0.100 GeneticVariation BEFREE <b>RESULTS:</b><i>CYP1B1</i> rs1056836 variant was associated with decreased risk of PCa [odds ratio (OR): 0.80; 95% confidence interval (CI): 0.68-0.99, <i>P</i> = 0.041]. 29344273

2018
dbSNP: rs12611084
rs12611084
SPINT2 ; PPP1R14A
0.010 GeneticVariation BEFREE <i>DPF1</i> rs12611084 was inversely associated with ER-negative breast, endometrioid ovarian, and overall and aggressive prostate cancer risk (OR = 0.93; 95% CI = 0.91-0.96; q = 0.005). 28115406

2017
dbSNP: rs2297441
rs2297441
TNFRSF6B ; RTEL1 ; RTEL1-TNFRSF6B
0.010 GeneticVariation BEFREE <i>RTEL1</i> rs2297441 [odds ratio (OR): 1.23; 95% confidence interval (CI): 1.03-1.46, <i>P</i> = 0.021] and rs3208008 (OR: 1.23; 95% CI: 1.03-1.46) were associated with PCa risk. 31762827

2019
dbSNP: rs3208008
rs3208008
TNFRSF6B ; RTEL1 ; RTEL1-TNFRSF6B
0.010 GeneticVariation BEFREE <i>RTEL1</i> rs2297441 [odds ratio (OR): 1.23; 95% confidence interval (CI): 1.03-1.46, <i>P</i> = 0.021] and rs3208008 (OR: 1.23; 95% CI: 1.03-1.46) were associated with PCa risk. 31762827

2019
dbSNP: rs10993994
rs10993994
MSMB
T 0.800 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs1447295
rs1447295
CASC8
A 0.800 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs16901979
rs16901979
PCAT1 ; CASC19
A 0.800 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs2735839
rs2735839 		G 0.800 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs4430796
rs4430796
HNF1B
A 0.800 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs6983267
rs6983267
POU5F1B ; CASC8 ; PCAT1 ; CCAT2
G 0.800 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs339331
rs339331
RFX6
T 0.760 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs12653946
rs12653946
CTD-2194D22.4
T 0.740 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs11649743
rs11649743
HNF1B ; LOC105371754
G 0.730 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs1465618
rs1465618
THADA
T 0.720 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs1983891
rs1983891
FOXP4
T 0.720 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs12621278
rs12621278
ITGA6
A 0.710 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs1512268
rs1512268
LOC107986930
T 0.710 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs2660753
rs2660753 		T 0.710 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs7837688
rs7837688 		T 0.710 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019